Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.

Abstract

To investigate the role of microsomal epoxide hydrolase (mEH) polymorphisms in the aetiology of lung cancer and to assess the interaction between mEH polymorphisms and smoking, we performed a meta-analysis of seven published studies, which included 2078 cases and 3081 controls, and a pooled analysis of eight studies (four published and four unpublished at… (More)

Topics

Cite this paper

@article{Cha2002MicrosomalEH, title={Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.}, author={Eun Shil Cha and Paul Brennan and Paolo Boffetta and Stephanie J London and Simone Benhamou and Agneta Rannug and Jordi To-Figueras and Magnus Ingelman-Sundberg and Peter Shields and Laura Gaspari and Emanuela Taioli}, journal={Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals}, year={2002}, volume={7 3}, pages={230-41} }